Cambridge Investment Research Advisors’s Innovator Equity Defined Protection ETF - 1 Yr March ZMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.93M Sell
245,533
-65,399
-21% -$1.83M 0.02% 813
2026
Q1
$8.58M Buy
310,932
+299,496
+2,619% +$8.28M 0.02% 679
2025
Q4
$314K Buy
11,436
+922
+9% +$25.1K ﹤0.01% 3156
2025
Q3
$285K Buy
10,514
+371
+4% +$9.94K ﹤0.01% 3153
2025
Q2
$269K Buy
+10,143
New +$264K ﹤0.01% 3073

Other funds holding ZMAR

Cambridge Investment Research Advisors's ZMAR Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Innovator Equity Defined Protection ETF - 1 Yr March (ZMAR) stake by 21% in Q2 2026, selling an estimated $1.83M and leaving 245,533 shares worth $6.93M. The position accounts for 0.02% of the portfolio, ranked #813.

Cambridge Investment Research Advisors first reported a position in ZMAR in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.58M in Q1 2026. 39 funds tracked by Wall St. Rank hold ZMAR as of Q2 2026.

  • Cambridge Investment Research Advisors held 245,533 shares of Innovator Equity Defined Protection ETF - 1 Yr March worth $6.93M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 65,399 Innovator Equity Defined Protection ETF - 1 Yr March shares in Q2 2026, an estimated $1.83M.
  • Innovator Equity Defined Protection ETF - 1 Yr March made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #813 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator Equity Defined Protection ETF - 1 Yr March in Q2 2025 and has held it in 5 quarters since.
  • Cambridge Investment Research Advisors's Innovator Equity Defined Protection ETF - 1 Yr March position peaked at $8.58M in Q1 2026.
  • 39 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr March as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.